Health Care & Life Sciences » Pharmaceuticals | Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc. | Ownership

Companies that own Eagle Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Henderson Global Investors Ltd.
1,891,298
12.73%
-15,062
0.06%
06/30/2018
BlackRock Fund Advisors
1,356,407
9.13%
165,335
0.01%
06/30/2018
Park West Asset Management LLC
1,103,556
7.43%
52,282
3.08%
06/30/2018
Hudson Executive Capital LP
971,000
6.53%
0
12.02%
06/30/2018
Iridian Asset Management LLC
860,911
5.79%
-12,220
0.54%
06/30/2018
SSgA Funds Management, Inc.
667,242
4.49%
-152,673
0%
06/30/2018
Victory Capital Management, Inc.
666,534
4.49%
-352,149
0.09%
06/30/2018
The Vanguard Group, Inc.
594,262
4%
30,256
0%
06/30/2018
LSV Asset Management
592,642
3.99%
-266,500
0.05%
06/30/2018
JW Asset Management LLC
475,755
3.2%
0
9.82%
06/30/2018

About Eagle Pharmaceuticals

View Profile
Address
50 Tice Boulevard
Woodcliff Lake New Jersey 07677
United States
Employees -
Website http://www.eagleus.com
Updated 07/08/2019
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka. The company was founded by Scott L.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.